| Patents for C07D 241 - Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings (18,673) |
|---|
| 09/16/2009 | EP2099756A1 N-hydroxyacrylamide compounds |
| 09/16/2009 | EP1487807B1 Cyano-pyrrolidines as DPP-IV inhibitors |
| 09/16/2009 | CN101531640A Preparation method of quizalofop-p-ethyl with high optical content |
| 09/16/2009 | CN101531565A Novel organic electroluminescent compounds and organic electroluminescent device using the same |
| 09/15/2009 | US7589105 Preventives or remedies for alzheimer's disease, or amyloid protein fibril-formation inhibitors, which include a nitrogen-containing heteroaryl compound |
| 09/15/2009 | US7589094 N- (3-amino-2-hydroxy-propyl) substituted alkylamide compounds |
| 09/15/2009 | US7589093 2,3-Dimethylindolo[2,3-b]quinoxaline-6-yl-acetamide; 9-Chloro-2,3-dimethyl-6-(aminoethylamino-2-oxoethyl)-6H-indolo[2,3-b]quinoxaline; autoimmune diseases |
| 09/15/2009 | US7589091 2(R)-Benzyloxymethyl-4-[4-(4-chloro-phenyl)-piperazin-1-yl]-N-hydroxy-3(S)-(4-methoxy-phenyl)-4-oxo-butyramide; inhibiting matrix metalloproteinase; immunosuppression; neuropathic pain |
| 09/15/2009 | CA2504399C Process for the preparation of arylamides of heteroaromatic carboxylic acids |
| 09/15/2009 | CA2359463C Novel polyhydroxypyrazine derivatives, preparation and pharmaceutical compositions containing same |
| 09/11/2009 | WO2009111442A1 AMINO-QUINOXALINE AND AMINO-QUINOLINE COMPOUNDS FOR USE AS ADENOSINE A2a RECEPTOR ANTAGONISTS |
| 09/11/2009 | WO2009110217A1 Hydroxyapatite with silver supported on the surface thereof |
| 09/11/2009 | WO2009109259A1 Pyrazinone derivatives as insulin secretion stimulators, methods for obtaining them and use thereof for the treatment of diabetes |
| 09/11/2009 | WO2009109258A1 Quinoxalinone derivatives as insulin secretion stimulators, methods for obtaining them and use thereof for the treatment of diabetes |
| 09/11/2009 | CA2717753A1 Pyrazinone derivatives as insulin secretion stimulators, methods for obtaining them and use thereof for the treatment of diabetes |
| 09/11/2009 | CA2717718A1 Quinoxalinone derivatives as insulin secretion stimulators, methods for obtaining them and use thereof for the treatment of diabetes |
| 09/11/2009 | CA2717171A1 Amino-quinoxaline and amino-quinoline compounds for use as adenosine a2a receptor antagonists |
| 09/11/2009 | CA2715835A1 Amide compounds, compositions and uses thereof |
| 09/10/2009 | US20090227791 Active Esters of N-Substituted Piperazine Acetic Acids, Including Isotopically Enriched Versions Thereof |
| 09/10/2009 | US20090227790 A kit for treating a disorder characterized by loss of dopaminergic and/or motoneurons, for treating Parkinson's disease, amyotrophic lateral sclerosis (ALS), or limiting damage to neuronal cells by Parkinsonian conditions |
| 09/10/2009 | US20090227594 Aliphatic amide & ester pyrazinoylguanidine sodium channel blockers |
| 09/10/2009 | US20090227592 Compounds effecting glucokinase |
| 09/10/2009 | US20090227591 Cyclopentene compounds |
| 09/10/2009 | US20090227585 Substituted n-heterocycle derivatives and methods of their use |
| 09/10/2009 | US20090227558 Amino-derivatives as novel inhibitors of histone deacetylase |
| 09/10/2009 | US20090227530 Sodium channel blockers |
| 09/09/2009 | EP2098120A2 2-alkyl-cycloalk(en) yl-carboxamides |
| 09/09/2009 | CN101524356A Use of dopamine D3 receptor ligands for production of drugs for treating renal function disorders |
| 09/09/2009 | CN100537548C Method of producing 3- methyl group - quinoline -2- carboxylic acid |
| 09/09/2009 | CN100537547C 2,5,6-three substitution pyrazine derivatives |
| 09/08/2009 | US7585976 chemical intermediate for Hemiasterlin, first isolated from the sponge Hemiasterella; anticarcinogenic agent for treatment of colon cancer, tumor; prevention of restenosis of blood vessels subject to traumas such as angioplasty and stenting |
| 09/08/2009 | US7585885 Beta -secretase (BACE); Alzheimer's disease; 2-(R)-[2-(S)-Amino-3-(3,5-difluorophenyl)-1-(S)-hydroxypropyl]-pyrrolidine-1-carboxylic acid tert-butyl ester |
| 09/08/2009 | US7585878 2-[(2,5-dimethylpyrrolidin-1-yl)methyl]-N-(1-methyl-2-oxo-1,2,3,4-tetrahydroquinolin-7-yl)biphenyl-4-carboxamide; capsaicin receptor VR1 inhibitory activity; inflammatory pain and neurogenic pain, migraine, cluster headache, bladder diseases including overactive bladder |
| 09/08/2009 | US7585864 1,1-Dimethyl-4-(8-chloro-5,11-dihydro-[1]benzoxepino[4,3-b]pyridin-11(S)-yl)-2(R)-[[[3-(4-methyl-1H-imidazol-1yl)propyl]phenylmethyl)amino]carbonyl]-1-piperazinecarboxylate |
| 09/08/2009 | US7585863 Antitumor agents; such as (2-(4-(7-Chloro-2-quinoxalinyl)oxy)propionylamino ethansulfonic acid; {2-{4-(7-Chloro-quinoxalin-2-yloxy)-phenoxy}propionyl amino}acetic acid |
| 09/08/2009 | US7585858 N-((4-((( 1R)-3 -(dimethylamino)-1-((phenylsulfanyl)methyl)propyl)amino)-3-nitrophenyl)sulfonyl)-4-(4-(2-fluorobenzyl)-4-methoxy-1-piperidinyl)benzenecarboximidamide; trigger apoptosis through the inhibition of the Bcl family of proteins |
| 09/08/2009 | US7585853 Compounds having selective inhibiting effect at GSK3 |
| 09/08/2009 | CA2442270C Inhibitors of akt activity |
| 09/08/2009 | CA2360360C Piperidyl benzamide compounds, composition containing same and their use thereof |
| 09/08/2009 | CA2314339C N-benzyl-3-indenylacetamide derivatives for treating neoplasia |
| 09/08/2009 | CA2295090C 2,4,4-trisubstituted-1,3-dioxolane antifungals |
| 09/08/2009 | CA2213466C Inhibitors of microsomal triglyceride transfer protein and method |
| 09/03/2009 | WO2009108657A2 Heteroaryl derivatives as cftr modulators |
| 09/03/2009 | WO2009107736A1 Fibrosis inhibitor |
| 09/03/2009 | WO2009055467A3 Compounds that inhibit protease cathepsin s and hcv replication |
| 09/03/2009 | US20090221823 Optically active carbamates, process for preparation thereof and use thereof as pharmaceutical intermediates |
| 09/03/2009 | US20090221607 Piperazine Derivatives |
| 09/03/2009 | US20090221603 Heterocyclic amide derivatives as calcium channel blockers |
| 09/03/2009 | US20090221596 Substtituted aryl oximes |
| 09/03/2009 | US20090221583 such as 4-Benzenesulfinyl-N-{2-oxo-2-[4-(2-trifluoromethyl-benzoyl)-piperazin-1-yl]-ethyl}-benzamide, used for the treatment of syndrome X, obesity, insulin resistance, dyslipidemia and cardiovascular diseases |
| 09/03/2009 | US20090221582 Piperazine Derivatives And Their Use In Therapy |
| 09/03/2009 | US20090221547 Immunosuppressant Compounds and Compositions |
| 09/03/2009 | US20090220454 Use of the histone deacetylase inhibitor N-hydroxy-4-[2-(3-dimethylaminobenzofuran-2-ylcarbonylamino)ethoxy]benzamide (aka CRA-24781, PCI-24781) for treating myelogenous leukemia (MML) or acute myelogenous leukemia (AML), optionally in combination therapy |
| 09/03/2009 | CA2716109A1 Heteroaryl derivatives as cftr modulators |
| 09/02/2009 | EP2096108A1 Novel organic electroluminescent compounds and organic electroluminscent device using the same |
| 09/02/2009 | EP2094656A2 P<0}{0pyrrol derivatives, preparation and use of the same in therapy<0} |
| 09/02/2009 | CN101522644A Pyrazine-2-carboxamide derivatives as cb2 receptor modulators |
| 09/02/2009 | CN101519379A Method for preparing 5-methylprazine-2-carboxylic acid |
| 09/01/2009 | US7582661 Antagonists of the chemokine receptor 9 (CCR9); inhibit TECK ligand; antiinflammatory agents and immunoregulators; inflammatory bowel disease; 2-Amino-5-chloro-phenyl)-(3-methyl-pyridin-4-yl)-methanone |
| 09/01/2009 | US7582657 Vanilloid receptor ligands and their use in treatments |
| 09/01/2009 | US7582639 Thiocolchicine dimers linked through linear aliphatic amido or amido-ureido bridge; antiproliferative, antiinflammatory, antiarthritic, antiviral agents; cytotoxicity; piperazinedicarboxylic acid bis-(N-deacetylthiocolchicine) amide derivatives; acts on cells expressing multidrug resistant phenotypes |
| 09/01/2009 | US7582432 Multiplexing methods using dark quenchers, nonfluorescing disazo dyes, functionalized for their rapid attachment to probe components; engineered to have a desired light absorption profile; facilitate interaction between quencher and fluorophore without form nucleic acid secondary structure |
| 08/27/2009 | WO2009105498A1 Anilinopyridines as inhibitors of fak |
| 08/27/2009 | US20090216017 Process for producing biaryl compound |
| 08/27/2009 | US20090216015 Base Stable Ionic Liquids |
| 08/27/2009 | US20090216013 e.g.1,1-Dicyclohexyl-3-[5-(pyridin-2-ylsulfanyl)-thiazol-2-yl]-urea; useful for the management, treatment, control, or adjunct treatment of diseases, where increasing glucokinase activity is beneficial, in particular, type 2 diabetes |
| 08/27/2009 | US20090215786 Novel cysteine protease inhibitors and their therapeutic applications |
| 08/27/2009 | US20090215782 Use of PDE-5 Inhibitors for Endothelial Repair of Tissues Impaired by Trauma or Disease |
| 08/27/2009 | US20090215736 inhibitors of apoptosis and IL-1 beta secretion; mediate cell apoptosis and inflammation; good cell penetration and pharmacokinetic properties; [3S/R(2S)]3-[2-(Carbazol-9-yl-2-oxo-ethyl)-pentanoylamino]-5-fluoro-4-oxo-pentanoic acid |
| 08/27/2009 | US20090214453 Use of Transmission Dyes for Protecting Human Skin From Browning and Ageing |
| 08/27/2009 | US20090214444 Poly aromatic sodium channel blockers |
| 08/26/2009 | EP2091942A1 Substituted pyrazinone derivatives for use as a medicine |
| 08/26/2009 | CN101516856A Heterocyclic bridged biphenyls and their use in oleds |
| 08/26/2009 | CN101514192A Quinoxalinone derivative with activity for reversing tumor cell multidrug resistance and preparation method thereof |
| 08/25/2009 | US7579469 For therapy of disease characterized by inflammatory, allergic, or proliferative processes |
| 08/25/2009 | US7579467 N-phenyl-2-pyrimidine-amine derivatives |
| 08/25/2009 | US7579411 Process for the controlled increase in the molecular weight of polyethylenes |
| 08/25/2009 | US7579347 Vanilloid receptor ligands and their use in treatments |
| 08/25/2009 | CA2405172C Alpha,beta-unsaturated sulfones for treating proliferative disorders |
| 08/19/2009 | EP2089355A2 Modulators of glucocorticoid receptor, ap-1, and/or nf- kappa b activity and use thereof |
| 08/19/2009 | EP2035394B1 2-pyrazinecarboxamide derivatives |
| 08/19/2009 | EP1513802B1 Alpha-sulfonylamino-acetonitriles |
| 08/19/2009 | EP1470114B1 Peptide nucleic acid oligomers from 1-benzenesulfonyl-3-amino acid side chain-4-(2-nucleobase(acetyl))-piperazin-2-ones |
| 08/19/2009 | CN101511823A Multifunctional bioactive compounds |
| 08/19/2009 | CN101511806A New heterocyclic compounds containing nitrogen atoms or pharmaceutically acceptable salts thereof, process for the preparation thereof and pharmaceutical composition comprising the same for treatment |
| 08/19/2009 | CN101511799A Cyclic amine compound |
| 08/19/2009 | CN101511789A 5,6-bisaryl-2-pyridine-carboxamide derivatives, preparation and application thereof in therapeutics as urotensin II receptor antagonists |
| 08/19/2009 | CN101511785A Substituted benzyl amine compounds |
| 08/19/2009 | CN101511775A Butyl and butynyl benzyl amine compounds |
| 08/19/2009 | CN101511362A Aqueous formulation comprising an antitumor agent |
| 08/19/2009 | CN101508679A Synthesis of D(-)-alpha-(4-ethyl-2,3-dioxygen ethylene imine-1-formamido) p-hydroxybenzene acetic acid |
| 08/18/2009 | US7576201 dihydro-disubstituted phenazine; includes (1) beta -(10-phenazine)propoxy phosphonic acid; (2) beta -(10-phenazine)propyl-phosphonic acid; and (3) beta -(10-phenazine)propionate phosphonic acid; p-type redox promoters and redox chromophores |
| 08/18/2009 | US7576198 A hydroxy compound containing substituted orpyridine, pyrazine, pyrimidine, oxazole, thiadiazole, quinoline, isoquinoline etc. as anti HIV agent, for treating AIDS |
| 08/18/2009 | US7576127 Aromatic prodrugs of propofol, compositions and uses thereof |
| 08/18/2009 | US7576087 3-(Phenylsulfonyl)-7-piperazin-1-yl-1H-pyrazolo[4,3-b]pyridine; 5-HT receptor subtype 5HT6; selective serotonin receptor antagonist; cognition actiators; alzheimer's disease; attention deficit disorder; antidepressant; antiepileptic agent; anxiolytic agents; obsessive compulsive disorder; Parkinson's |
| 08/18/2009 | US7576086 N1-benzyl-N4-(phenylpropane-2-yl-3-ol)piperazine; triple action on hydroxytryptamine (5-HT), noradrenalin (NA)and dopamine(DA); on brain synapses; cytochrome P-450 monooxygenase enzyme system antagonists; enzyme inhibitors; side effect reduction |
| 08/13/2009 | WO2009100431A1 Cysteine and cystine prodrugs to treat schizophrenia and reduce drug cravings |
| 08/13/2009 | WO2009100261A2 Improved process for making triphenylboron-pyridine compound |
| 08/13/2009 | WO2009099174A1 Therapeutic agent or preventive agent for inflammatory bowel disease containing amino alcohol derivative as active ingredient |
| 08/13/2009 | WO2009075857A3 Glycine transporter-1 inhibitors |